
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-03-05-2014
 - Volume 10
 - Issue 3
 
Croda Receives Two EXCiPACT Certifications
Croda receives two achievements in relation to EXCiPACT.
Croda
, a global supplier of specialty ingredients, reports it has received two achievements in relation to EXCiPACT, the voluntary system that reduces the audit burden in the pharmaceutical industry by providing independent third-party certification of manufacturers, suppliers, and distributors of excipients.
Croda’s first EXCiPACT certification covers ingredients manufactured at Rawcliffe Bridge in the UK. This achievement is part of a global program to gain accreditation at the six Croda sites that supply pharmaceutical excipients. In addition, the company reports that Croda’s Head of Global Quality Assurance, Iain Moore, was singled out for driving EXCiPACT forward in a speech by Frank Milek, Chair of The International Pharmaceutical Excipients Council Europe at their annual seminar in Cannes.
Source: 
Croda
Articles in this issue
over 11 years ago
Top 10 Outsourcing Trends in Biopharmaceutical Manufacturingover 11 years ago
Local Knowledge Drives Global Market Expansionover 11 years ago
Regulatory Initiatives Spur API Supply Chain Securityover 11 years ago
Reaching China's Clinical Trial Marketover 11 years ago
MedImmune Announces Research Collaboration with UC SanFranciscoover 11 years ago
Inflammatory Diseases Explained in Artistic Designsover 11 years ago
Almac Adds New Blistering TechnologyNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





